Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of a Six-Week Mindfulness-Based Intervention on Glycemic Control, Cardiovascular Autonomic Function, Anxiety, and Depression in Adults With Type 2 Diabetes: A Randomized Controlled Trial

NCT07936357 is registered in ClinicalTrials.gov with Universitas Sebelas Maret Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07936357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of a Six-Week Mindfulness-Based Intervention on Glycemic Control, Cardiovascular Autonomic Function, Anxiety, and Depression in Adults With Type 2 Diabetes: A Randomized Controlled Trial
Lead sponsor
Universitas Sebelas Maret Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2025
Completion date
June 30, 2025
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression, diabetic autonomic neuropathy, type 2 diabetes mellitus

Arms

As registered; 2 arms.

  • Mindfulness plus standard therapy ExperimentalSix-week audio-guided mindfulness program

    Participants continued their standard antidiabetic therapy and completed a six-week audio-guided mindfulness program delivered through WhatsApp.

  • Standard therapy No intervention

    Participants continued their standard antidiabetic therapy without the mindfulness program.

Primary endpoints

Registered primary outcome measures; 3 primary.

  • Change in glycated hemoglobin (HbA1c) Baseline and 6 weeks

    HbA1c (%) measured with a point-of-care analyzer (Afinion HbA1c, Abbott). Change was calculated as the 6-week value minus the baseline value.

  • Change in fasting blood glucose Baseline and 6 weeks

    Venous blood glucose after an 8-10-hour fast, measured with an enzymatic photometric method (mg/dL). Change was calculated as the 6-week value minus the baseline value.

  • Change in 2-hour postprandial blood glucose Baseline and 6 weeks

    Venous blood glucose 2 hours after a meal, measured with an enzymatic photometric method (mg/dL). Change was calculated as the 6-week value minus the baseline value.

Lead sponsor's other trials

Universitas Sebelas Maret Hospital, most recent start first.

Similar trials

Same condition (Diabetic Neuropathies) and phase, most recent start first.